News on U.S. government agencies, U.S. politics, companies doing business with U.S. federal government. Read U.S. national and local news. This site is not affiliated with United States Government.
(USGovernment-News.Com, June 13, 2012 ) New York, NY -- VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, has issued updates on four companies followed by vfcsstockhouse.com.
Implant Sciences, Synergy Pharmaceuticals, Teletouch Communications and NovaBay Pharmaceuticals.
NovaBay Pharmaceuticals (NBY): A solid day of trading for NovaBay Pharmaceuticals (NBY) on Tuesday placed the share price back at the $1.20 mark, barely two weeks after the stock was hitting intra-day lows of ninety cents. A modest mid-week runup that began last week fueled the move to the one-twenty mark, a significant move in terms of percentages.
Teletouch Communications (TLLE): Teletouch Commications (TLLE) has been making a play as a growth story of late, following the settled resolution of litigation with AT&T (T) that filled the cash coffers with a few bucks, and that trend continued this week as the company announced that Cellphone-Mate, Inc., a leading designer and manufacturer of high quality wireless signal amplifiers and repeater systems, has signed a multi-year contract with Teletouch subsidiar, Progressive Concepts, Inc. dba PCI Wholesale, who will now become an exclusive "Master Distributor" of Cellphone-Mate products.
Implant Sciences (IMSC): A key catalyst that is just months away could launch Implant Sciences (IMSC) into the mainstream of homeland defense and global security. The Transportation Security Administration (TSA) is currently reviewing Implant's explosives and narcotics trace detection technology for approval for use in the United States and a potential positive approval ruling would not only provide a key catalyst for the IMSC share price, but it would open the doors for Implant to quickly become a global leader in providing airport and air cargo security, among other security-related services.
Synergy Pharmaceuticals (SGYP): Volume has been steadily on the rise for shares of Synergy Pharmaceuticals (SGYP), and as a result, the share price has been inching higher as well. SGYP closed Monday having traded just about double the daily norm after a mid-day volume spike that led to a closing price a couple of percentage points higher than the open. The strong-volumed trend continued into Tuesday's trading, another day where SGYP shares registered a gain of a few percentage points.
VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks, biopharma stocks, growth stocks and the pharmaceutical and healthcare sectors. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights into broader-market news through various 'Stock Watch' lists. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFC’s Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and devise their own entry and exit strategies.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Industry resource center today to browse our selection of 600+ complimentary Industry magazines, white papers, webinars, podcasts, and more. Get popular titles including:
